Fundraising FoxScandiBio
Stockholm, SE · 1 known investors
Find your way into ScandiBio
Sign up to see every warm intro you have to ScandiBio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ScandiBio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ScandiBio Therapeutics is a biotechnology company developing therapeutics based on research from leading Swedish and UK academic institutions. The company was founded by researchers from KTH Royal Institute of Technology, Karolinska Institutet, Sahlgrenska Academy, and King's College London.
Founders & leadership
AM
Adil MardinogluDr
MU
Mathias UhlenProfessor
JB
Jan BorenProfessor
ON
Olof NordCEOOlof Nord holds a doctorate in biotechnology and a master's degree in chemical engineering, and brings over 25 years of experience in life sciences, healthcare, and medtech industries across multiple executive and leadership roles, including previous founding of a biopharmaceutical company.
Investors · 1
Frequently asked questions
- What does ScandiBio do?
- ScandiBio Therapeutics is a biotechnology company developing therapeutics based on research from leading Swedish and UK academic institutions. The company was founded by researchers from KTH Royal Institute of Technology, Karolinska Institutet, Sahlgrenska Academy, and King's College London.
- Who founded ScandiBio?
- ScandiBio was founded by Adil Mardinoglu, Mathias Uhlen, Jan Boren.
- Who are ScandiBio's investors?
- ScandiBio's investors include Navigare Ventures.
- Where is ScandiBio headquartered?
- ScandiBio is headquartered in Stockholm, SE.